Deutsche Bank’s Nexvet Biopharma plc Ordinary Shares NVET Stock Holding History

Deutsche Bank’s Portfolio NVET Stock Details NVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-3,500	Closed	-$23K	–	5311
2017 Q2	$23K	Buy	3,500 +2,917	+500%	+$18.3K	﹤0.01%	4544
2017 Q1	$2K	Hold	583	–	–	﹤0.01%	4802
2016 Q4	$2K	Sell	583 -600	-51%	-$2.48K	﹤0.01%	4833
2016 Q3	$4K	Sell	1,183 -82	-6%	-$389	﹤0.01%	4788
2016 Q2	$5K	Hold	1,265	–	–	﹤0.01%	5015
2016 Q1	$4K	Hold	1,265	–	–	﹤0.01%	4995
2015 Q4	$4K	Sell	1,265 -8,285	-87%	-$32.7K	﹤0.01%	5098
2015 Q3	$34K	Hold	9,550	–	–	﹤0.01%	4602
2015 Q2	$47K	Sell	9,550 -670	-7%	-$4.64K	﹤0.01%	4620
2015 Q1	$82K	Buy	+10,220	New	+$96.7K	﹤0.01%	4207

Deutsche Bank's NVET Position: Q3 2017 in Review

Deutsche Bank sold out of Nexvet Biopharma plc Ordinary Shares (NVET) in Q3 2017, closing a stake of 3,500 shares — an estimated $23K sold.

Deutsche Bank first reported a position in NVET in Q1 2015 and held it in 10 quarters. The position peaked at $82K in Q1 2015. 0 funds tracked by Wall St. Rank hold NVET as of Q3 2017.

Deutsche Bank reported no remaining Nexvet Biopharma plc Ordinary Shares position as of Q3 2017 after selling out during the quarter.
Deutsche Bank sold 3,500 Nexvet Biopharma plc Ordinary Shares shares in Q3 2017, an estimated $23K.
Deutsche Bank first reported a position in Nexvet Biopharma plc Ordinary Shares in Q1 2015 and held it in 10 quarters.
Deutsche Bank's Nexvet Biopharma plc Ordinary Shares position peaked at $82K in Q1 2015.
0 funds tracked by Wall St. Rank held Nexvet Biopharma plc Ordinary Shares as of Q3 2017.

Based on Deutsche Bank's 13F filing for Q3 2017, filed 14 Nov 2017.